Verition Fund Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-201,475
| Closed | -$369K | – | 2847 |
|
|
2024
Q4 | $369K | Buy |
+201,475
| New | +$369K | ﹤0.01% | 2038 |
|
|
2024
Q2 | – | Sell |
-14,316
| Closed | -$53.7K | – | 2506 |
|
|
2024
Q1 | $53.7K | Buy |
+14,316
| New | +$53.7K | ﹤0.01% | 2018 |
|
|
2023
Q4 | – | Sell |
-31,800
| Closed | -$266K | – | 2134 |
|
|
2023
Q3 | $266K | Buy |
+31,800
| New | +$266K | ﹤0.01% | 1491 |
|
|
2023
Q1 | – | Sell |
-15,382
| Closed | -$126K | – | 2118 |
|
|
2022
Q4 | $126K | Sell |
15,382
-8,063
| -34% | -$66K | ﹤0.01% | 1422 |
|
|
2022
Q3 | $136K | Buy |
+23,445
| New | +$136K | ﹤0.01% | 1969 |
|
|
2018
Q4 | – | Sell |
-23,697
| Closed | -$128K | – | 1051 |
|
|
2018
Q3 | $128K | Hold |
23,697
| – | – | ﹤0.01% | 1122 |
|
|
2018
Q2 | $84K | Hold |
23,697
| – | – | 0.01% | 960 |
|
|
2018
Q1 | $49K | Buy |
+23,697
| New | +$49K | ﹤0.01% | 1025 |
|
|
2016
Q3 | – | Sell |
-15,000
| Closed | -$106K | – | 1158 |
|
|
2016
Q2 | $106K | Buy |
+15,000
| New | +$106K | 0.01% | 742 |
|
|
2015
Q3 | – | Sell |
-16,585
| Closed | -$96K | – | 652 |
|
|
2015
Q2 | $96K | Buy |
+16,585
| New | +$96K | 0.02% | 529 |
|
|
2014
Q1 | – | Sell |
-137,918
| Closed | -$721K | – | 581 |
|
|
2013
Q4 | $721K | Buy |
137,918
+105,394
| +324% | +$551K | 0.13% | 97 |
|
|
2013
Q3 | $180K | Sell |
32,524
-22,676
| -41% | -$125K | 0.03% | 435 |
|
|
2013
Q2 | $139K | Buy |
+55,200
| New | +$139K | 0.03% | 498 |
|